or Try an Advanced Search...

    Technical Analysis for SGMT - Sagimet Biosciences Inc.

    Grade Last Price % Change Price Change
    F 4.06 3.57% 0.14
    SGMT closed up 3.57 percent on Friday, April 26, 2024, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical SGMT trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 3.57%
    Narrow Range Bar Range Contraction 3.57%
    Wide Bands Range Expansion 3.57%
    Gapped Down Weakness 3.57%
    Oversold Stochastic Weakness 3.57%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.64%
    Inside Day Range Contraction -2.64%
    Older End-of-Day Signals for SGMT ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 19 hours ago
    Up 5% about 19 hours ago
    Rose Above Previous Day's High about 20 hours ago
    Outside Day about 20 hours ago
    60 Minute Opening Range Breakout about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SGMT Chart by TradingView
    Basic chart:

    Profile

    Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne

    Is SGMT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 26 Sagimet Biosciences' Denifanstat Imminent Phase 3: A Promising Investment Opportunity
    Apr 22 Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024
    Mar 27 Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat
    Mar 25 Sagimet stock jumps 23% in wake of Q4 report, business updates
    Mar 25 Sagimet Biosciences GAAP EPS of -$2.66 beats by $34.65, revenue of $2M in-line
    Mar 25 Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
    Mar 25 Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
    Feb 29 Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
    Feb 6 Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy
    Jan 26 KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    See more SGMT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.71
    52 Week Low 2.13
    Average Volume 816,882
    200-Day Moving Average 0.00
    50-Day Moving Average 5.37
    20-Day Moving Average 4.69
    10-Day Moving Average 4.13
    Average True Range 0.43
    RSI (14) 37.89
    ADX 13.2
    +DI 18.75
    -DI 24.97
    Chandelier Exit (Long, 3 ATRs) 4.76
    Chandelier Exit (Short, 3 ATRs) 5.13
    Upper Bollinger Bands 5.86
    Lower Bollinger Band 3.51
    Percent B (%b) 0.23
    BandWidth 50.17
    MACD Line -0.41
    MACD Signal Line -0.40
    MACD Histogram -0.0179
    Fundamentals Value
    Market Cap 123.32 Million
    Num Shares 30.4 Million
    EPS -1.18
    Price-to-Earnings (P/E) Ratio -3.44
    Price-to-Sales 99.52
    Price-to-Book 1.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.47
    Resistance 3 (R3) 4.45 4.30 4.40
    Resistance 2 (R2) 4.30 4.20 4.31 4.37
    Resistance 1 (R1) 4.18 4.13 4.24 4.20 4.35
    Pivot Point 4.03 4.03 4.06 4.04 4.03
    Support 1 (S1) 3.91 3.93 3.97 3.93 3.77
    Support 2 (S2) 3.76 3.86 3.77 3.75
    Support 3 (S3) 3.64 3.76 3.72
    Support 4 (S4) 3.66